Amgen Inc (NASDAQ: AMGN)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $336.74
-
Support level$299.50
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)85.7
- AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- AMGN is one of this month's top performers with a return of 12.7 percent, beating 90 percent of stocks in the S&P-100.
- Up 5.2 percent, AMGN is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $258.59 | $338.45 | 98.1% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $293.55 | $294.91 | $308.52 | $321.98 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.8%
-
In the next month13.5%
-
In the next year54.0%
| Period | Value |
|---|---|
| Historical (5 year) | 23.6% |
| Last month | 22.6% |
| Current estimate | 25.0% |
| Next month forecast | 23.8% |